Cuprina Holdings (Cayman) (NASDAQ:CUPR – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.05) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $0.01 million during the quarter.
Cuprina Holdings (Cayman) Price Performance
Shares of CUPR opened at $0.29 on Tuesday. The company has a 50-day moving average price of $0.36. Cuprina Holdings has a one year low of $0.28 and a one year high of $9.50.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cuprina Holdings (Cayman) in a research note on Friday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
About Cuprina Holdings (Cayman)
We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.
Recommended Stories
Receive News & Ratings for Cuprina Holdings (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cuprina Holdings (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
